| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate |
1992-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91863b6f922465b946acef22d5cb9165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f287cc0d62c7acbcd17b8a8dcc6ab9d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856475f5a0045ddb6c4ef0c0e4ce2cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9e2540a6bad5aeeacdbd5497050e8da |
| publicationDate |
1995-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H07188037-A |
| titleOfInvention |
Physiological ophthalmic compound and method for producing the same |
| abstract |
(57) [Summary] [PROBLEMS] To provide a novel physiological ophthalmic formulation having substantially the same ionic component composition as the ionic components of normal human tears and containing no preservative. [Structure] Potassium ions at a concentration of 11 to 25 mmol / l, calcium ions at a concentration of 0.2 to 0.5 mmol / l, and magnesium at a concentration of 0.15 to 0.45 mmol / l. The ingredients of the formulation containing at least the ions and bicarbonate ion at a concentration of between 1 and 36 mmol / l are mixed in a suitable container and the formulation is transferred to a pressure reaction vessel where the unstable components are in equilibrium. To reach the desired equilibrium state between the gas and the unstable component, and a sufficient amount of gas that shows the equilibrium state between the gas and the unstable component is mixed for a sufficient time to form a physiological ophthalmic formulation. To manufacture. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008081439-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100339954-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03057228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005530537-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2003057228-A1 |
| priorityDate |
1991-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |